Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota community refers to the aggregate of microorganisms—primarily bacteria but also fungi, viruses, archaea, and protozoa—that inhabit the gastrointestinal tract, predominantly the colon, of humans and other animals[1][2][5]. This microbial ecosystem plays a crucial role in digestion (especially of complex carbohydrates and fibers that the host cannot digest unaided), synthesizes essential vitamins (such as B vitamins and vitamin K), produces important metabolites like short-chain fatty acids, and interacts closely with the host immune system[1][5]. The gut microbiota also protects against pathogens by occupying ecological niches and modulates numerous physiological processes, including contributing to metabolic homeostasis and the gut-brain axis, which can influence behavior[1][2][4][5]. The composition of the gut microbiota varies greatly between individuals and is influenced by factors such as diet, genetics, age, and antibiotic exposure[1][2][3]. Critical note: The gut microbiota community is not a single molecular target, receptor, enzyme, or protein, but rather a highly diverse and dynamic ecosystem of microorganisms[1][2][3][5]. Although modulating the gut microbiota is an emerging therapeutic strategy, it is not accurate to classify the "gut microbiota community" as a canonical molecular target comparable to a receptor or enzyme. Its immense diversity, complexity, and interdependence with host and environment mean that it is more usefully viewed as a therapeutic system or modulatable ecosystem rather than a traditional drug target[2][4][5].
Modulation of microbial composition (antibiotics, probiotics, FMT); Alteration of metabolite production (e.g., short-chain fatty acids, bile acids); Immune system modulation
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota community.